TrustCore Financial Services’s Arena Pharmaceuticals Inc ARNA Stock Holding History

TrustCore Financial Services’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30	Closed	-$3K	–	1131
2021 Q4	$3K	Hold	30	–	–	﹤0.01%	860
2021 Q3	$2K	Hold	30	–	–	﹤0.01%	968
2021 Q2	$2K	Hold	30	–	–	﹤0.01%	994
2021 Q1	$2K	Hold	30	–	–	﹤0.01%	878
2020 Q4	$2K	Hold	30	–	–	﹤0.01%	862
2020 Q3	$2K	Hold	30	–	–	﹤0.01%	792
2020 Q2	$2K	Hold	30	–	–	﹤0.01%	829
2020 Q1	$1K	Hold	30	–	–	﹤0.01%	865
2019 Q4	$1K	Hold	30	–	–	﹤0.01%	881
2019 Q3	$1K	Hold	30	–	–	﹤0.01%	936
2019 Q2	$2K	Hold	30	–	–	﹤0.01%	856
2019 Q1	$1K	Hold	30	–	–	﹤0.01%	826
2018 Q4	$1K	Hold	30	–	–	﹤0.01%	438
2018 Q3	$1K	Hold	30	–	–	﹤0.01%	820
2018 Q2	$1K	Hold	30	–	–	﹤0.01%	938
2018 Q1	$1K	Hold	30	–	–	﹤0.01%	685
2017 Q4	$1K	Buy	+30	New	+$855	﹤0.01%	663

TrustCore Financial Services's ARNA Position: Q1 2022 in Review

TrustCore Financial Services sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 30 shares — an estimated $3K sold.

TrustCore Financial Services first reported a position in ARNA in Q4 2017 and held it in 17 quarters. The position peaked at $3K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

TrustCore Financial Services reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
TrustCore Financial Services sold 30 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3K.
TrustCore Financial Services first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 17 quarters.
TrustCore Financial Services's Arena Pharmaceuticals Inc position peaked at $3K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on TrustCore Financial Services's 13F filing for Q1 2022, filed 9 May 2022.